Eukaryotic-Prokaryotic Chimeras for Structure-Function Studies of the Intracellular Domain of Cys-Loop Receptors  by Goyal, Raman et al.
Sunday, February 26, 2012 117a588-Pos Board B374
Eukaryotic-Prokaryotic Chimeras for Structure-Function Studies of the
Intracellular Domain of Cys-Loop Receptors
Raman Goyal, Andrew Navetta, Sita Nirupama Nishtala,
Ahmed A. Salahudeen, Jonathan E. Pauwels, Nelli Mnatsakanyan,
Michaela Jansen.
Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Receptors belonging to the Cys-loop gene superfamily of neurotransmitter-
gated ion channels (e.g. acetylcholine, serotonin, GABA, and glycine recep-
tors) mediate fast synaptic transmission. These receptors are targeted by a
number of clinically used drugs (e.g. antiepileptics, antipsychotics, anes-
thetics). Cys-loop receptors contain three domains: extracellular (ECD), trans-
membrane (TMD), intracellular (ICD). The ECD and TMD have been studied
in great detail and their 3-D structures have been determined. The recent iden-
tification of bacterial Cys-loop receptor homologues has propelled the struc-
tural knowledge to atomic resolution. However, all prokaryotic members
lack the ICD. The ICD of metazoan Cys-loop receptors is the most diverse do-
main with respect to both length and amino-acid composition. The ICD there-
fore represents an attractive target for developing subtype-selective drugs with
the promise of fewer side effects than drugs that target the highly-conserved
ECDandTMD.We have engineered functional chimeraswith ICDs fromdiffer-
ent eukaryotic receptors in the two-domain prokaryotic homologue GLIC (one
chimera set published, Goyal, Salahudeen, Jansen, JBC 2011). Based on struc-
ture predictions others have hypothesized that the ICD is mainly unstructured,
but contains an a-helical segment pre-TM4.We hypothesize based on computa-
tional results that cationic and anionic receptors have different ICD secondary
structures, i.e., only cationic receptors contain an a-helical portion pre-TM4.
For each eukaryotic ICD we generated 12 chimeras that differ by the linkers
both N- and C-terminal to the inserted ICD. Interestingly, the number of
functional chimeras in each set varies drastically between different ICDs. We
are testing the functional consequences of inserting various ICDs using electro-
physiological studies, and investigating the structure of the ICDs tethered to the
TMD and at the lipid bilayer with spectroscopic and biochemical methods.
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Neuronal nicotinic acetylcholine receptors (nAChRs) are abundantly expressed
in the central nervous system. Neurons in several brain regions co-express
alpha5, alpha4 and beta2 subunits. Changes in the receptor composition and
stoichiometry of alpha4 and beta2 containing nAChRs are pertinent to disease
states. Several genome-wide association and candidate gene studies have iden-
tified polymorphisms in the gene for the alpha5 subunit that are linked to an
increased risk for nicotine addiction, alcohol addiction and lung cancer. How-
ever more information is required about the functional effects of incorporating
a normal or mutated alpha5 subunit into the alpha4beta2 receptor pentamer.
Here we examine differences in I-V relationships and dose-response relations
between alpha4beta2 receptors and alpha4beta2 receptors including alpha5
subunits containing various mutations to the M2 domain expressed in Xenopus
oocytes.
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Ivermectin (IVM) is a broad-spectrum anthelmintic drug used to treat human
parasitic diseases like onchocerciasis (river blindness) and elephantiasis (lym-
phatic filariasis). IVM acts on invertebrate Cys-loop receptors (GluClRs) that
naturally bind the neurotransmitter glutamate (Glu) to open an intrinsic
chloride-selective channel. Native heteropentameric GluCla/bRs are irrevers-
ibly stabilized in an open-channel conformation by IVM. Hence, IVM causes
sustained inflow of chloride ions and hyperpolarization that suppress nervous
impulses in nematodes. Consequently, vital physiological processes in the
nematode are abolished. Upon expression in Xenopus oocytes, homomeric
GluClaRs are activated (being opened) by IVM but not by Glu, whereas ho-
momeric GluClbRs are activated by Glu but not by IVM (Cully et al., Nature,
1994). A heteromeric GluCla/bR carrying a mutation in the b-subunit that in-
hibits Glu binding is readily activated by IVM (Li et al., FEBS Lett, 2002).
These differential responses suggest that the drug and the neurotransmitterbinding sites are independent of each other. Yet, a recent X-ray crystal struc-
ture shows that IVM-bound homomeric GluClaR can accommodate Glu
(Hibbs and Gouaux, Nature, 2011), in line with a study showing that robust
activation of homomeric GluClaRs by IVM enables further (slight) activation
by Glu (Etter et al., JBC, 1996). Here, we explored whether the structurally
separated IVM and Glu binding sites are functionally coupled in heteromeric
GluCla/bRs. Mutations introduced between the Glu and IVM binding pockets
or inside the IVM binding pocket were examined for their influence on ago-
nistic efficacies. We found mutations that improve IVM efficacy without
changing Glu efficacy, and mutations that either reduce or increase the ago-
nistic efficacies of IVM and Glu concomitantly. Our results strongly indicate
that the IVM and Glu binding sites in heteromeric GluClRs are functionally
coupled.
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Nicotinic acetylcholine receptors (nAChR) are ligand gated cation channels
that are opened by agonists like Acetylcholine and Nicotine. They are widely
distributed in neurons all over central nervous system, where they are mainly
found at postsynaptic locations of cholinergic nerve endings.
The most abundant homomeric nicotinic acetylcholine receptors in the mam-
malian brain are the pentameric alpha7 nAChRs which consist of five alpha7
subunits. Each subunit provides an orthosteric low affinity binding site for its
endogenous ligand, acetylcholine. Several lines of evidence suggest a link
between the alpha7 neuronal nicotinic acetylcholine receptor and brain disor-
ders including schizophrenia, Alzheimer’s disease, and traumatic brain injury.
Alpha 7 receptors are also a target for non-CNS indications like diabetes and
asthma.
Here we show the results of the
screen of allosteric modulators
on alpha 7 receptors. High par-
allelization without a compro-
mise in data quality combined
with fast and accurate solution
exchange allows characteriza-
tion of many compounds. A
second analysis at physiological
temperatures showed a pro-
nounced effect on the allosteric
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We report the finding of a new putative cholesterol-recognition motif in the
transmembrane region of membrane proteins like the nicotinic acetylcholine re-
ceptor (AChR) and other members of the Cys-loop superfamily of neurotrans-
mitters involved in rapid synaptic transmission, as well as in members of the
important superfamily of G protein coupled receptors (GPCRs) involved in Alz-
heimer’s disease. The motif is an inverted CRAC domain (cholesterol recogni-
tion/interaction amino acid consensus) which we have named CARC and is
present in the transmembrane regions of the receptor subunits having extensive
contact with the surrounding lipid, predominantly in the first (TM1) segment in
the case of the AChR, and optimally suited to convey cholesterol-mediated sig-
naling. Three cholesterol molecules could be docked on the transmembrane re-
gions of the five human AChR subunits, rendering a total of 15 cholesterol
molecules per AChR molecule, adding up to a total of about 200 kJ.mol-1 per
receptor molecule, i.e. ~40% of the total lipid solvation free energies for the
whole AChR molecule. The novel motif is remarkably conserved among Cys-
loop receptors along the phylogenetic scale, from prokaryotes to humans, its
high degree of conservation suggesting that it could be responsible for some
of the structural/functional properties of these transduction macromolecules.
Reference: Baier, C.J., Fantini, J. and Barrantes, F.J. (2011). Sci. Rep. 1:00069.
